NAPOLEON CUENCO: Open Payments
NPI 1841237211 · GALAX, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$177 in 8 payments from 4 companies in 2025. Trend: 2023 $418 · 2024 $130 · 2025 $177
Food & beverage: $177
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 5 | $113 |
| Otsuka America Pharmaceutical, Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
Products named: COBENFY, REXULTI, CAPLYTA, UZEDY.
Industry payments across VA — which companies pay providers there.
